Description
Product details
CAPECITIME 500 Capecitabine lp (500mg) CAPECITIME 500 represents a significant advancement in the landscape of oncological therapeutics. Manufactured with stringent quality standards by Steris Healthcare, this pharmaceutical product contains Capecitabine IP 500mg, a potent antimetabolite chemotherapy agent. It is designed to offer a balance of high efficacy and patient convenience, shifting the paradigm of cancer care from exclusively hospital-based intravenous treatments to a manageable, home-based oral regimen. In the complex battle against malignancy, precision and tolerability are paramount. CAPECITABINE 500 serves as a 'prodrug'—a medication that remains largely inactive until it enters the body. Once ingested, it undergoes a unique three-step enzymatic conversion process, transforming into its active cytotoxic form, 5-fluorouracil (5-FU), preferentially within tumor tissues. This mechanism aims to maximize the destruction of cancer cells while striving to spare healthy tissues, making CAPECITABINE 500 a cornerstone therapy for patients battling colorectal, breast, and gastric cancers. Mechanism of Action: The Science of CAPECITIME 500 Understanding how CAPECITIME 500 works is essential to appreciating its value. Unlike traditional chemotherapy that attacks all rapidly dividing cells indiscriminately, Capecitabine is designed to be smarter. Absorption and Conversion: Upon swallowing the CAPECITIME 500 tablet, the drug is absorbed through the intestinal wall. It passes through the liver, where it is converted into an intermediate compound. Tumor Targeting: The final conversion to the active cancer-killing agent, 5-FU, occurs primarily in the presence of an enzyme called thymidine phosphorylase. Research indicates that this enzyme is often found in higher concentrations in tumor tissues compared to normal healthy tissues. DNA Disruption: Once active inside the cancer cell, the drug mimics essential nutrients the cell needs to grow (specifically inhibiting thymidylate synthase). This effectively 'starves' the cancer cell of the building blocks required for DNA replication and repair, leading to cell death (apoptosis) and slowing tumor progression. Therapeutic Indications and Uses CAPECITABINE 500 is a versatile oncology medication prescribed by specialists for several specific types of cancer. Its efficacy is well-documented in various clinical settings: 1. Colorectal Cancer Adjuvant Treatment: CAPECITIME 500 is widely used for patients with Stage III (Dukes' C) colon cancer who have undergone surgery to remove the primary tumor. In this setting, the drug acts as a 'cleanup' agent, targeting any microscopic cancer cells that may remain, significantly reducing the risk of recurrence and improving survival rates. Metastatic Colorectal Cancer: For cases where the cancer has spread (metastasized) to other parts of the body, CAPECITIME 500 is often the first-line treatment. It can be used as a standalone therapy (monotherapy) or in combination with other chemotherapy agents to control disease progression. 2. Breast Cancer Advanced or Metastatic Disease: CAPECITIME 500 plays a critical role in treating advanced breast cancer. It is frequently prescribed when the cancer has stopped responding to other standard chemotherapy treatments, such as paclitaxel or anthracyclines. Combination Therapy: It is often paired with other drugs (e.g., docetaxel) to enhance the attack on cancer cells, providing a synergistic effect that can shrink tumors more effectively than single agents alone. 3. Gastric (Stomach) Cancer CAPECITABINE 500 is also a key component in the treatment regimen for advanced gastric cancer, often used in combination with platinum-based chemotherapy. It helps in palliative care settings to extend survival and improve the quality of life for patients with inoperable tumors. Key Benefits of CAPECITIME 500 Patients and healthcare providers choose CAPECITABINE 500 for several distinct advantages that set it apart from conventional intravenous chemotherapy. 1. Convenience of Oral Administration Perhaps the most immediate benefit for the patient is the form factor. Traditional 5-FU treatment requires continuous intravenous (IV) infusion, necessitating frequent hospital visits, catheter lines, or portable pumps. CAPECITIME 500 is a tablet. This allows patients to take their medication in the comfort of their own homes, reducing hospital visits and allowing them to maintain a more normal daily routine, work schedule, and family life. 2. Targeted 'Tumor-Activated' Therapy Because the drug is converted to its active form largely within the tumor site (due to higher enzyme levels there), CAPECITIME 500 achieves high concentrations of medicine exactly where it is needed—inside the cancer. This targeted approach aims to reduce systemic toxicity compared to older chemotherapy methods that flood the entire bloodstream with active toxins. 3. Proven Efficacy & Quality Manufactured by Steris Healthcare, CAPECITIME 500 adheres to WHO-GMP (Good Manufacturing Practices) standards, ensuring that patients receive a product of high purity, stability, and consistent dosage. Clinical data supports that oral Capecitabine is at least equivalent to intravenous 5-FU in terms of survival outcomes for colorectal cancer, with the added benefit of improved convenience. 4. Flexible Combination Partner CAPECITIME 500 is highly versatile. It can be effectively combined with a wide range of other cancer therapies, including radiation therapy and biologic agents, allowing oncologists to tailor treatment plans to the specific genetic makeup and stage of the patient's cancer. Potential Side Effects and Management While CAPECITIME 500 is designed to be more targeted, it is still a potent chemotherapy drug, and side effects can occur. Being aware of these helps patients manage them effectively. Common Side Effects Gastrointestinal Issues: Diarrhea, nausea, vomiting, and abdominal pain are common. These are usually manageable with dietary changes and additional medications prescribed by the doctor. Fatigue: A general sense of tiredness or weakness is frequently reported. Hand-Foot Syndrome (Palmar-Plantar Erythrodysesthesia): This is a specific side effect where the palms of the hands and soles of the feet become red, swollen, tender, or peel. It is caused by small amounts of the drug leaking from capillaries in these areas. Serious Side Effects (Rare but Important) Cardiac Symptoms: Rarely, patients may experience chest pain or heart palpitations. Low Blood Cell Counts: The drug can temporarily lower the number of white blood cells (increasing infection risk), red blood cells (anemia), and platelets (bruising). Severe Diarrhea: If left untreated, this can lead to dehydration. Managing Side Effects Hydration: Patients are advised to drink plenty of fluids. Skin Care: For Hand-Foot Syndrome, keeping hands and feet moisturized, avoiding tight shoes, and staying away from hot water/heat sources is recommended. Communication: Early reporting of side effects to a healthcare provider often allows for dose adjustments that can stop the side effects from becoming severe. Dosage and Administration Prescription Only: CAPECITABINE 500 is a prescription-only medicine and must be taken exactly as directed by an oncologist. Typical Cycle: A common regimen involves taking the tablets twice daily (morning and evening) for 14 consecutive days, followed by a 7-day rest period. This constitutes one 21-day cycle. With Food: It is crucial to take CAPECITIME 500 within 30 minutes after a meal with water. Taking it with food reduces the risk of stomach upset and ensures proper absorption. Conclusion CAPECITIME 500 (Capecitabine 500mg) stands as a vital therapeutic option in modern oncology. By combining the potency of traditional chemotherapy with the smart science of tumor-enzyme activation, it offers a powerful weapon against colorectal, breast, and gastric cancers. Beyond its chemical efficacy, CAPECITIME 500 offers the profound benefit of dignity and independence. The ability to self-administer chemotherapy at home empowers patients, reducing the burden of clinical visits and allowing them to focus more on healing and living. With its high-quality formulation by Steris Healthcare, CAPECITIME 500 provides a reliable, effective, and patient-centric solution for cancer management.
